FAKTOR-OPTIONSSCHEIN - AB SCIENCE Stock

DE000MA5WZ99

Delayed Börse Stuttgart 04:44:01 2024-05-28 am EDT
0.022 ^EUR	-18.52%

3 months	-12.00%
6 months	-72.84%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AB SCIENCE

Latest news about AB SCIENCE

AB Science reports its revenues for the year 2023 and provides an update on its activities	May. 15	GL
AB Science: European patent granted for masitinib	May. 13	CF
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036	May. 13	GL
AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient	May. 07	GL

More news

Quotes 5-day view

Date	Price	Change
24-05-28	0.022	-18.52%
24-05-27	0.027	+8.00%
24-05-24	0.025	0.00%
24-05-23	0.025	0.00%
24-05-22	0.025	-3.85%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 04:44 am EDT

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	AB SCIENCE
Issuer	Morgan Stanley
WKN	MA5WZ9
ISIN	DE000MA5WZ99
Date issued	2021-03-26
Strike	0.9862 €
Maturity	Unlimited
Parity	43.21 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	13.22 €
Lowest since issue	0.015 €

Company Profile

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Sector

More about the company

Consensus: AB Science

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.972 EUR

Average target price

6.895 EUR

Spread / Average Target

+249.65%

Consensus